Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04940871

Study to Assess the Efficacy and Safety of Favipiravir-HU

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Favipiravir-HU Compared to Placebo as add-on Therapy to Standard of Care in Asymptomatic to Mild Severity COVID-19 Patients

Clinical Trial Summary

The aim of the study is to assess the safety and efficacy of Favipiravir HU when administered to SARS-Cov- 2 patients in order to offer a safe and effective treatment to SARS-Cov-2 infection during the pandemic. The study is not for registration purposes and is not part of a series of studies for registration of Favipiravir HU.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Severe Acute Respiratory Syndrome
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Clinical Trial Details
NCT number NCT04940871
Study type Interventional
Source University of Pecs
Contact
Status Terminated
Phase Phase 2
Start date November 25, 2021
Completion date November 29, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04768998 - Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
Terminated NCT04642638 - Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure Phase 2/Phase 3
Completed NCT04588363 - COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
Completed NCT05249816 - Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine Phase 3
Recruiting NCT04863547 - Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
Terminated NCT04389840 - Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure Phase 2/Phase 3
Completed NCT04933929 - Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization N/A
Completed NCT04725084 - Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome
Completed NCT04851821 - The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) Phase 1
Withdrawn NCT05545319 - A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 Phase 2
Terminated NCT04391309 - COVID-19 and Anti-CD14 Treatment Trial Phase 2
Completed NCT04343261 - Convalescent Plasma in the Treatment of COVID 19 Phase 2